Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop [Seeking Alpha]
Ardelyx, Inc. (NASDAQ: ARDX) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $5.50 price target on the stock, down previously from $11.00.
Ardelyx Responds to District Court Decision Granting Motion to Dismiss [Yahoo! Finance]
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference